virtual patent marking notice
This website is provided to satisfy the virtual patent marking provisions of various jurisdictions including the virtual patent marking provisions of United States law, and to provide notice under 35 U.S.C. Section 287(a). The following list of products may not include all of Axogen’s products. The patents identified for each product may also not be all inclusive. For example, some products listed below may be protected by patents of the United States or another country and which are not identified below. Other products not listed here may be protected by one or more patents of the United States or elsewhere.
| Avance® Nerve Graft Product codes for United States: Product codes for Germany: Product codes for all other countries: | U.S. Patent 9,690,975 U.S. Patent 9,996,729 U.S. Patent 10,311,281 U.S. Patent 10,783,349 U.S. Patent 11,847,844 Additional foreign patents have been issued. Additional U.S. and foreign patents are pending. |
| Axoguard Nerve Cap® Product codes for United States, New Zealand: | U.S. Patent 9,629,997 U.S. Patent 10,945,805 U.S. Patent 10,952,806 U.S. Patent 11,147,645 U.S. Patent 12,279,916 U.S. Patent 12,285,299 Additional foreign patents have been issued. Additional foreign patents are pending. |
| Avive+ Soft Tissue Matrix™ | U.S. Patent 11,577,001 U.S. Patent 12,263,276 Additional U.S. and foreign patents are pending. |
| Axoguard HA+ Nerve Protector® | U.S. and foreign patents pending. |
There’s only a short form between you and our nerve product team who can help you get more information about our nerve repair solutions.